Date published: 2026-4-23

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cdk/Crk Inhibitor (CAS 784211-09-2)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1-(2,6-Dichlorophenyl)-1,5-dihydro-6-((4-(2-hydroxyethoxy)phenyl)methyl)-3-(1-methylethyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one; RGB-286147; Cdk7 Inhibitor IV
Application:
Cdk/Crk Inhibitor is a pyrazolo-pyrimidinone compound that acts as a potent, selective & ATP-competitive inhibitor of Cdks
CAS Number:
784211-09-2
Purity:
>95%
Molecular Weight:
473.4
Molecular Formula:
C23H22Cl2N4O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Cdk/Crk Inhibitor is a cell-permeable pyrazolo-pyrimidinone compound that acts as a potent, selective, and ATP-competitive inhibitor of Cdks (IC50 = 48 nM, 15 nM, 9 nM, 10 nM, 71 nM, and 9 nM for Cdk1/B, Cdk2/E, Cdk3/E, Cdk5/p35, Cdk7/H/MAT1, and Cdk9, respectively). It inhibits Cdk4/D1, Cdk6/D3, and GSK-3b only at much higher concentrations (IC50 = 839 nM, 282 nM, and 754 nM, respectively) and exhibits little activity towards a panel of 60 other kinases. Cdk/Crk Inhibitor is a broad-spectrum growth inhibitor toward tumor cells, but not non-transformed quiescent fibroblasts.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Cdk/Crk Inhibitor, 1 mg

sc-203872
1 mg
$290.00